Eli Lilly & Co.

DuPont Analysis: Decomposition of ROE
Quarterly Data

An approach to decomposing Eli Lilly & Co.'s return on equity as the product of other financial ratios.

• Two-Component Disaggregation of ROE
• Three-Component Disaggregation of ROE
• Two-Way Decomposition of ROA

Income Statement

The income statement (statement of earnings) reports on the performance of Eli Lilly & Co., the result of its operating activities.

Statement of Financial Position, Assets

The assets reports major classes and amounts of resources owned or controlled by Eli Lilly & Co..

Common-Size Statement of Financial Position, Assets

Assets components shown as percentage of total assets.

Common Stock Valuation Ratios
Quarterly Data

Relative valuation technique determine the value of Eli Lilly & Co. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock's value, such as earnings, book value, and sales.

• Historical Valuation Ratios (Summary)
• Price to Earnings (P/E)
• Price to Operating Profit (P/OP)
• Price to Sales (P/S)
• Price to Book Value (P/BV)

Statement of Financial Position, Liabilities and Stockholders' Equity

The liabilities and stockholders' equity reports major classes and amounts of external claims on assets and owners' capital contributions, and other internally generated sources of capital.